Full Text RR-93-002 NATIONAL RESOURCE FOR TRANSGENIC ANIMALS NIH Guide, Volume 22, Number 13, April 2, 1993 RFA: RR-93-002 P.T. 34 Keywords: Animal Breed. & Facil., Scientific Genetics National Center for Research Resources Application Receipt Date: June 23, 1993 PURPOSE The National Center for Research Resources (NCRR) invites applications to establish National Resource(s) for Transgenic Animals, to be awarded competitively in Fiscal Year 1993. The primary objectives of this initiative are to: (1) create a repository of embryos of transgenic rodents and lagomorphs, and (2) conduct research to perfect cryopreservation methods for important animal species. This award will establish a resource center where embryos are preserved, maintained (banked), and distributed; where transgenic animals are produced at request from the maintained embryos; and where research is conducted on cryopreservation techniques. ELIGIBILITY REQUIREMENTS Applications may be submitted by domestic, for-profit and non-profit organizations, public and private, such as universities, colleges, laboratories, hospitals, or medical centers. Applications from foreign institutions are ineligible for the P40 mechanism. Applicant institutions must demonstrate an established research and resource base in areas related to the Request for Applications (RFA). Underrepresented minorities, persons with disabilities, and women are encouraged to apply. MECHANISM OF SUPPORT Grants awarded in response to this initiative will be via the NCRR Animal (Mammalian and Nonmammalian Model), and Animal and Biological Material Resource Grant (P40) mechanism. Responsibility for the planning, direction, and execution of the proposed project will be solely that of the applicant. Awards will be administered under Public Health Service (PHS) grants policy as stated in the PHS Grants Policy Statement and in this RFA. The total project period for applications submitted in response to the RFA may not exceed five years and is renewable. The earliest expected award date is September 30, 1993. Applicants must limit their requests to not more than $350,000 direct costs for the initial budget period. Future budget period escalations may not exceed a four percent increase over the previous budget period. This RFA is a one-time solicitation. Future unsolicited competing continuation applications will compete with all investigator-initiated applications and will be reviewed according to the customary peer review procedures. FUNDS AVAILABLE The estimated funds (total costs) available for the first year of support for this activity are approximately $1,000,000. It is anticipated that one or two awards will be made in FY 93 with an average size of approximately $500,000 total costs. However, the specific number of awards will depend upon the scientific merit and scope of the applications received and the availability of funds. RESEARCH OBJECTIVE Background The laboratory mouse is presently the most widely used, available, and economical animal model used in biomedical research and, in particular, transgenic research. In addition to the many traditional mutant mouse strains, hundreds of additional strains of mice have been created in recent years through transgenic technology. The methods presently available to preserve, maintain, and produce this proliferating number of strains include active breeding programs and embryo cryopreservation. Breeding is expensive and often duplicative. Cryopreservation of embryos is less expensive, but is technologically intensive and heavily dependent on mouse husbandry. These handicaps are clearly resulting in the loss of many strains and limiting access to other users. The development of refined technology for harvesting and successfully cryopreserving mouse sperm and reconstitution of strains through in vitro fertilization or artificial insemination and relatively simple breeding procedures offer a very promising alternative to the current situation. An NCRR-sponsored conference on Development of Transgenic Animal Model Resources was held in November 1990. This conference recommended the development of transgenic technology and cryopreservation of transgenic embryos and sperm. Improved preservation of animal genetic resources through cryopreservation was also recommended in the 1990 Report of the Committee on Preservation of Laboratory Animal Resources, Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council. Objectives The objective of this RFA is to initiate a long-term, stable, integrated program for safeguarding national research animal resources of importance to research projects sponsored by the PHS. This initiative will: 1) Provide support to a limited number of centers to serve as multi-categorical research and service resources for the preservation and supply of transgenic rodent and lagomorph strains. These centers are to be regional in nature, and serve users throughout the United States. 2) Encourage applied research on the development of improved techniques for cryopreservation of eggs, sperm, and embryos of numerous rodent and lagomorph species. 3) Incorporate the resources/equipment for the freezing and maintenance of embryos, sperm, and eggs of transgenic animals, and provide, on a full cost recovery basis, live animals from the embryos. A plan will be developed that describes the cost recovery procedures to be implemented. 4) Provide a means for more extensive and long term support to maintain the embryos of those rodent and lagomorph species and models considered to be of national importance and that cannot be preserved through alternate methods. 5) Establish a national advisory committee to review, plan, and prioritize national needs for preservation of important laboratory animal resources. This committee will also act as a central point for the review and evaluation of stocks to be accepted into the repository. It is suggested that the committee be composed of no fewer than five members, with the Principal Investigator serving as the chairperson of the committee. It is encouraged that a minimum of two members be appointed from outside the institution receiving the grant. It is suggested that the committee meet formally at least twice a year during the first year, and then at least once a year thereafter. Conference calls may be held on an as-needed basis to coordinate and plan the activities of the center. 6) Establish effective cooperation with other institutions and organizations with similar interests to minimize costs and avoid duplication. 7) Establish a modern database for classification of all embryos maintained by the resource, maintenance of nomenclature for transgenic embryos being held, and tracking distribution of all embryos or animals provided to users of the resource. 8) Encourage users who have developed transgenic animals with research funds provided through the National Institutes of Health (NIH) to store constructs in these centers. 9) Encourage self-sufficiency of the centers at the end of the project period. A detailed plan will be developed that describes how self-sufficiency will be achieved. For the purposes of this RFA, users of the centers are defined as those individuals who have peer-reviewed research projects involving transgenic animals, with first priority given to those funded by the NIH, followed by those funded by other agencies of the PHS, followed by other sources of peer-reviewed research support. APPLICATION PROCEDURES Applications are to be submitted on form PHS 398 (rev. 09/91), available at most institutional offices of sponsored research and from the Office of Grants Inquiries, Division of Research Grants, National Institute of Health, 5333 Westbard Avenue, Room 449, Bethesda, MD 20892, telephone (301) 710-0267. For item 2a of the face page of the application, applicants must enter RFA: National Resource for Transgenic Animals, RFA RR-93-002. The RFA label available in the form PHS 398 must be affixed to the bottom of the face page. Failure to use this label could result in delayed processing of the application to the extent that it may not reach the review committee in time for review. Applications must be received by close of business June 23, 1993. If an application is received after this date, it will be returned to the applicant. Submit a signed, typewritten original and three signed photocopies of the application to: Application Receipt Office Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** At the time of submission, two additional copies of the application must also be sent to: Dr. Bernadette Tyree Office of Review National Center for Research Resources Westwood Building, Room 10A16 Bethesda, MD 20892 The Division of Research Grants (DRG) will not accept any application in response to this RFA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. Nor will the DRG accept any application that is essentially the same as one already reviewed. This does not preclude the submission of substantial revisions of applications already reviewed, but such applications must include an introduction addressing the previous critique. Budgetary Considerations - Allowable Costs Unless otherwise indicated, allowable costs and policies governing the research grant programs of the NIH will prevail. Overlapping support between the grant and other NIH grants and contracts to the applicant institution will be administratively reviewed and, if appropriate, will be adjusted to avoid duplication of funding. Support may be requested for salaries of professional, technical, and support personnel who contribute to allowable activities under the grant. The salaries derived from the grant will depend on the effort provided and institutional salary policies. Stipends for research fellows/trainees are not allowable. No overlap of time or effort between the grant and other separately funded projects is permitted. Support for secretarial and administrative staff may be provided to the extent that their activities relate to administrative management of the grant activities, providing these costs have not been included in the institution's indirect cost pool. It is expected that most major equipment necessary to carry out this work will already be available. However, requests for major equipment under this RFA will be considered; this would include, but not be limited to, equipment for producing and maintaining (freezing) transgenic embryos, ova, and sperm. General purpose equipment needs may be included and justified only after surveying the availability of such items within the institution. While costs of animal maintenance (i.e., per diem charges) for research animals are allowable, it is expected that the costs of production of live animals from transgenic embryos will be recovered from the users through a cost recovery system. Applicants should separately identify all costs related to the maintenance of research animals and to animal production. Costs of domestic travel for grant personnel and advisory committee members are allowable. Foreign travel will not be allowed except under unusual and compelling circumstances, and will require prior approval by the awarding agency. Costs for consultant services (consultation fees, per diem, travel) may be included. Costs associated with consultation or scientific or technical assistance, evaluation of planning activities, and development of new techniques are allowable. Costs for telephone, facsimile transmissions, photocopying, and computer time that are directly related to the grant are permitted. REVIEW CONSIDERATIONS Upon receipt, applications will be examined initially by DRG for completeness. Incomplete applications will be returned to the applicant without further consideration. Evaluation of responsiveness to the program requirements and criteria stated in this RFA is an NCRR staff function. Applications that are considered complete and responsive will be evaluated in accordance with the criteria stated below by an appropriate peer review group convened by the Office of Review of NCRR. It is essential that the written application be in a form that can be reviewed on its own merit, since no site visit is anticipated. If the number of applications is large compared to the number of awards to be made, the NCRR may conduct a preliminary scientific peer review to eliminate those applications that are clearly not competitive. The NCRR will administratively withdraw from competition those applications judged to be noncompetitive, and will so notify the applicant and the institutional business official. Applications judged to be both competitive and responsive to the RFA will be evaluated further, according to the review criteria stated below. Following initial merit review, the applications will receive a second-level review by the National Advisory Research Resources Council. The review of the grant applications will focus on scientific merit. The evaluation will include the following review criteria: 1. Overall Program o The potential of the center, as proposed, to meet the objectives stated in this RFA. o The scientific merit of the program as a whole, including the significance of the overall program goals and the development of a well-defined central focus. o The potential of the identified participants to develop research programs of high merit as evidenced by previous accomplishments. 2. Administration and Planning o The scientific and administrative leadership ability and experience of the grant's Principal Investigator and his/her commitment and ability to devote adequate time to the effective management of the center. o The composition of the advisory committee, and how the national needs for preservation of the laboratory animal resources will be reviewed, planned, and prioritized. o Maintenance of internal communication and cooperation among the investigators involved in the center, and adequacy of plans for such collaboration. o Appropriateness of the budget for the various components of the grant. o Appropriateness of the plan that details full cost recovery for production of live animals from embryos. o Appropriateness of the plan that describes how the resource will become self-sufficient by the end of the project period. o Quality of the plan to develop a database that will classify all embryos maintained by the resource; maintain nomenclature for transgenic embryos being held; and track distribution of all embryos or animals sent to users of the resource. 3. Scientific Expertise of Participants o Quality and appropriateness of expertise available at the applicant institution for research on the development of improved cryopreservation techniques, maintenance of animals, and development of the database. o Nature and degree of interdisciplinary approach proposed to promote the collaboration of scientists with expertise in transgenic animal methodology. o Qualifications, experience, and evidence of commitment of the investigators within the applicant institution, and their willingness to interrelate with other elements proposed for the center. 4. Institutional Commitment o The institutional commitment to the program, including lines of responsibility for the proposed center and the institution's contribution to the management capabilities of the center. o The degree of institutional contributions for administrative and planning activities. o The research environment and the availability of expertise, resources, equipment, and space for the freezing and maintenance of embryos, sperm, and eggs of transgenic animals. o The availability of expertise and resources required to provide users with live animals from embryos at their request. o The potential for interaction with scientists from other departments and institutions to minimize costs and avoid duplication. o The institutional commitment to any newly-recruited individuals responsible for conducting essential grant functions and activities. AWARD CRITERIA Applications will compete for available funds with all other applications submitted in response to this RFA and recommended by peer review. The following will be considered in making funding decisions: o Quality of the application as determined by peer review o Availability of funds o Overall program balance and geographic distribution represented by the applications recommended by peer review Schedule Application Receipt Date: June 23, 1993 Initial Review: July/August 1993 Second Level Review: September 1993 Anticipated Award: September 1993 INQUIRIES Written and telephone inquiries concerning this RFA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to: Dr. Cynthia L. Pond Laboratory Animal Sciences Program National Center for Research Resources Westwood Building, Room 857 5333 Westbard Avenue Bethesda, MD 20892 Telephone: (301) 594-7933 Direct inquiries regarding fiscal matters to: Ms. Kathy Springmann Office of Grants and Contracts Management National Center for Research Resources Westwood Building, Room 853 Bethesda, MD 20892 Telephone: (301) 594-7955 AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.306, Laboratory Animal Sciences and Primate Research. Awards will be made under authorization of the Public Health Service Act, Title III, Section 301 (Public Law 78.410, as amended; 42 USC 241) and administered under PHS grant policies and Federal Regulations 42 CFR Part 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||